JOILIFRI Trademark
Trademark Overview
On Tuesday, April 22, 2025, a trademark application was filed for JOILIFRI with the United States Patent and Trademark Office. The USPTO has given the JOILIFRI trademark a serial number of 79424972. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, May 26, 2026. This trademark is owned by TAIHO PHARMACEUTICAL CO., LTD.. The JOILIFRI trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of tumor; pharmaceutical preparations for the treatment of cancer; chemical reagents for medical purposes in the field of oncology; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for the treatment of dermatological diseases and disorders; pharmaceutical preparations for the treatment of muscular diseases and disorders; pharmaceutical preparations for the treatment of urological diseases and disorders; pharmaceutical preparations for the treatment of digestive diseases and disorders; pharmaceutical preparations for the treatment of gastroesophageal reflux diseases and disorders; pharmaceutical preparations for the treatment of hepatic diseases and disorders; pharmaceutical preparations for the treatment of renal diseases and disorders; pharmaceutical preparations for the treatment of autoim...
General Information
| Serial Number | 79424972 |
| Word Mark | JOILIFRI |
| Filing Date | Tuesday, April 22, 2025 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, May 26, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, May 26, 2026 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations for the treatment of tumor; pharmaceutical preparations for the treatment of cancer; chemical reagents for medical purposes in the field of oncology; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for the treatment of dermatological diseases and disorders; pharmaceutical preparations for the treatment of muscular diseases and disorders; pharmaceutical preparations for the treatment of urological diseases and disorders; pharmaceutical preparations for the treatment of digestive diseases and disorders; pharmaceutical preparations for the treatment of gastroesophageal reflux diseases and disorders; pharmaceutical preparations for the treatment of hepatic diseases and disorders; pharmaceutical preparations for the treatment of renal diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of diseases of the central and peripheral nervous system; pharmaceutical preparations for the treatment of rheumatoid arthritis; pharmaceutical preparations for the treatment of diseases of the blood; pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for use in chemotherapy; anti-emetic medicines; pharmaceutical preparations for the treatment of pain; analgesic preparations; antiphlogistic preparations |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, June 11, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | TAIHO PHARMACEUTICAL CO., LTD. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | JP |
| Party Name | TAIHO PHARMACEUTICAL CO., LTD. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | JP |
Trademark Events
| Event Date | Event Description |
| Thursday, May 29, 2025 | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB |
| Wednesday, June 11, 2025 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Friday, June 13, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, June 13, 2025 | APPLICATION FILING RECEIPT MAILED |
| Friday, July 4, 2025 | CORRECTION TRANSACTION RECEIVED FROM IB |
| Monday, September 15, 2025 | ASSIGNED TO EXAMINER |
| Monday, September 22, 2025 | NON-FINAL ACTION WRITTEN |
| Tuesday, September 23, 2025 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Sunday, November 9, 2025 | REFUSAL PROCESSED BY MPU |
| Sunday, November 9, 2025 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Sunday, November 30, 2025 | REFUSAL PROCESSED BY IB |
| Monday, April 27, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, April 27, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, April 27, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, April 28, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, April 29, 2026 | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED |
| Wednesday, May 20, 2026 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, May 26, 2026 | PUBLISHED FOR OPPOSITION |
| Tuesday, May 26, 2026 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
